阿替普酶靜脈溶栓治療急性腦梗死的效果及對神經(jīng)功能與生存質(zhì)量的影響

打開文本圖片集

【摘要】目的：探究阿替普酶靜脈溶栓治療急性腦梗死的效果及對神經(jīng)功能與生存質(zhì)量的影響。方法：篩取2019年1月—2022年6月期間院內(nèi)收治的共計(jì)90例急性腦梗死患者，按照隨機(jī)數(shù)表法將患者分為兩組，每組45例，對照組采用常規(guī)治療，試驗(yàn)組采用阿替普酶靜脈溶栓治療。比較兩組治療效果。結(jié)果：與對照組相比，試驗(yàn)組治療總有效率更高，P0.05；治療后，試驗(yàn)組NIHSS評分低于對照組，SF-36及ADL評分高于對照組，P

【關(guān)鍵詞】腦梗死；急性；阿替普酶；靜脈溶栓；神經(jīng)功能；生存質(zhì)量

The therapeutic effect of intravenous thrombolysis with alteplase on acute cerebral infarction and its impact on neurological function and quality of life

ZHANG Jinlong， QIANG Man

Qishan County Hospital， Baoji， Shaanxi 722400， China

【Abstract】Objective：To explore the therapeutic effect of intravenous thrombolysis with alteplase on acute cerebral infarction，as well as its impact on neurological function and quality of life.Methods：A total of 90 patients with acute cerebral infarction admitted to the hospital from January 2019 to June 2022 were selected.The patients were divided into two groups using the random number table method，with 45 cases in each group.The control group received conventional treatment，while the experimental group received intravenous thrombolysis with alteplase therapy.The therapeutic effects of the two groups were compared.Results：Compared with the control group，the total effective rate of treatment in the experimental group was higher，P0.05；After treatment，the NIHSS score of the experimental group was lower than that of the control group，while the SF-36 and ADL scores were higher than those of the control group，P

【Key Words】Cerebral infarction； Acute； Alteplase； Intravenous thrombolysis； Neurological function； Quality of life

急性腦梗死是一種由血栓等因素導(dǎo)致急性血管狹窄或閉塞，損傷腦組織，引起腦組織缺血壞死，導(dǎo)致神經(jīng)功能異常的疾病，具有較高的致殘率和致死率，嚴(yán)重威脅患者生命安全。（剩余4367字）